Patient Square Capital Acquires Stake in Nektar Therapeutics
On May 15, 2026, Patient Square Capital LP disclosed the purchase of 210,000 shares of Nektar Therapeutics (NKTR) for $11.96 million, representing a new position and accounting for 2.68% of its reportable AUM at quarter-end. The value of this stake increased to $15.11 million by the end of the first quarter due to price appreciation.
Tickers: $NKTR
Topics: biotech investor_activity SEC_filings